- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 30 residues within 4Å:- Chain A: C.15, A.16, L.40, G.41, N.42, G.44, V.45, L.46, W.48, G.105, R.106, T.107, N.108, L.127, S.128, R.129, T.130, N.144, K.145, V.146, L.164, G.165, G.166, S.167, V.168, V.169, Y.170, E.172, V.195
- Ligands: DQF.3
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:L.40
- Hydrogen bonds: A:A.16, A:L.40, A:N.42, A:G.44, A:R.106, A:T.107, A:T.107, A:N.108, A:S.128, A:R.129, A:R.129, A:T.130, A:G.165, A:S.167, A:V.168, A:V.169, A:E.172
- Salt bridges: A:R.106
- pi-Cation interactions: A:R.129
NDP.6: 30 residues within 4Å:- Chain B: C.15, A.16, L.40, G.41, N.42, G.44, V.45, L.46, G.105, R.106, T.107, N.108, S.111, L.127, S.128, R.129, T.130, N.144, K.145, V.146, L.164, G.165, G.166, S.167, V.168, V.169, Y.170, E.172, V.195
- Ligands: DQF.7
21 PLIP interactions:21 interactions with chain B- Hydrophobic interactions: B:L.40
- Hydrogen bonds: B:A.16, B:L.40, B:N.42, B:G.44, B:R.106, B:T.107, B:T.107, B:N.108, B:S.111, B:R.129, B:T.130, B:T.130, B:K.145, B:G.165, B:S.167, B:V.168, B:V.169, B:Y.170, B:E.172
- Salt bridges: B:R.106
- 2 x DQF: 4-[3-[3-[2,6-bis(azanyl)-5-(3-chlorophenyl)pyrimidin-4-yl]propoxy]phenoxy]butanoic acid(Non-covalent)
DQF.3: 15 residues within 4Å:- Chain A: I.14, C.15, A.16, V.45, L.46, D.54, F.58, N.108, S.111, I.112, L.119, L.164, Y.170, T.185
- Ligands: NDP.2
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:L.46, A:F.58, A:F.58, A:F.58, A:I.112, A:L.119
- Hydrogen bonds: A:I.14, A:L.46, A:Y.170, A:T.185, A:T.185
- Salt bridges: A:D.54
DQF.7: 15 residues within 4Å:- Chain B: I.14, C.15, A.16, V.45, L.46, D.54, M.55, F.58, N.108, I.112, P.113, L.164, Y.170, T.185
- Ligands: NDP.6
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:L.46, B:F.58, B:F.58, B:F.58, B:I.112
- Hydrogen bonds: B:I.14, B:L.46, B:T.185, B:T.185
- Salt bridges: B:D.54
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 6 residues within 4Å:- Chain A: V.453, Q.455, N.458, L.462, R.471
- Chain B: L.482
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.458, A:R.471
GOL.8: 7 residues within 4Å:- Chain A: W.477
- Chain B: V.453, Q.455, N.458, L.462, R.471, L.473
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.458, B:R.471
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saepua, S. et al., 6-Hydrophobic aromatic substituent pyrimethamine analogues as potential antimalarials for pyrimethamine-resistant Plasmodium falciparum. Bioorg.Med.Chem. (2019)
- Release Date
- 2019-12-04
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x DQF: 4-[3-[3-[2,6-bis(azanyl)-5-(3-chlorophenyl)pyrimidin-4-yl]propoxy]phenoxy]butanoic acid(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saepua, S. et al., 6-Hydrophobic aromatic substituent pyrimethamine analogues as potential antimalarials for pyrimethamine-resistant Plasmodium falciparum. Bioorg.Med.Chem. (2019)
- Release Date
- 2019-12-04
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B